Muhammad Hanzla Shahzad. Beyond Association: Clarifying the Biological and Clinical Value of Urinary EphA2 in Bladder Cancer. // International Journal of Urology. – 2026. – DOI: 10.1111/iju.70697. – URL: https://onlinelibrary.wiley.com/doi/10.1111/iju.70697?af=R
Muhammad Hanzla Shahzad (2026). Beyond Association: Clarifying the Biological and Clinical Value of Urinary EphA2 in Bladder Cancer. International Journal of Urology. https://doi.org/10.1111/iju.70697
Muhammad Hanzla Shahzad. “Beyond Association: Clarifying the Biological and Clinical Value of Urinary EphA2 in Bladder Cancer.” International Journal of Urology, 2026. doi:10.1111/iju.70697.
@article{Shahzad2026,
title = {Beyond Association: Clarifying the Biological and Clinical Value of Urinary EphA2 in Bladder Cancer},
author = {Shahzad, Muhammad Hanzla},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70697},
url = {https://onlinelibrary.wiley.com/doi/10.1111/iju.70697?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...